EU regulator recommends to stop sale of GSK's blood cancer drug

Reuters · 09/15/2023 12:52
EU regulator recommends to stop sale of GSK's blood cancer drug

- The European Medicines Agency's human medicines committee on Friday recommended against renewal of the conditional marketing authorisation for GSK's GSK.L blood cancer drug Blenrep.


(Reporting by Khushi Mandowara in Bengaluru; Editing by Shounak Dasgupta)

((Khushi.Mandowara@thomsonreuters.com))